Advertisement
Mydecine Innovations Group Inc.

Stay Updated with the Latest Mydecine Innovations Group Inc. MYCO.NE News in Real Time

Find MYCO.NE news now at Meyka AI. Stay informed with the latest Mydecine Innovations Group Inc. stocks updates, including price news, market analysis, and expert insights.

MYCO.NENEO
HealthcareDrug Manufacturers - Specialty & Generic
$0.35
$0.00(0.00%)
Canadian Market is Open · 10:56
Advertisement
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
📅 in about 3 hours

Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029

Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…

Read more 12
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
📅 in about 2 hours

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium

AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…

Read more 12
CRH Eyes $8 Billion Arcosa Acquisition, Potential Deal Values Target at 13.7x EBITDA
📅 in about 2 hours

CRH Eyes $8 Billion Arcosa Acquisition, Potential Deal Values Target at 13.7x EBITDA

CRH made its biggest-ever acquisition official on June 22, 2026, signing a definitive agreement to acquire Arcosa, Inc. (NYSE: ACA) in an all-cash transaction. CRH will pay $150 per share in cash, with the transaction valuing Arcosa at a total enterprise value of approximately $8.5 billion, representing an acquisition multiple of 11.5x 2026E Adjusted EBITDA,…

Read more 12
Tesla Inc (TSLA) +1.04%: Jefferies Revises Down Target, Highlights SpaceX Tracking Stock Risk
📅 in about 2 hours

Tesla Inc (TSLA) +1.04%: Jefferies Revises Down Target, Highlights SpaceX Tracking Stock Risk

Tesla Inc (TSLA) traded higher by about 1% in recent sessions in June 2026, even as Wall Street turned cautious. In a fresh note, Jefferies revised its price target lower and flagged new concerns around valuation pressure. The report also pointed to growing risks linked to SpaceX-related tracking stock sentiment and Elon Musk’s wider business…

Read more 12
EasyJet (LON: EZJ) Stock Rises 2.74% After Rejecting £4.7 Billion Acquisition Offer
📅 in about 1 hour

EasyJet (LON: EZJ) Stock Rises 2.74% After Rejecting £4.7 Billion Acquisition Offer

easyJet shares surged on June 22, 2026, climbing 2.74% as the airline went public with a dramatic takeover standoff. Minneapolis-based asset manager Castlelake made a first cash bid for easyJet of 560 pence per share on June 12. It followed by a second offer of 600p on June 17. A third proposal of 625p per…

Read more 12
Voltas Shares (NSE: VOLTAS) Surge 3.89% as AC Sales Cross 1 Million Mark in Record Q1 FY27
📅 2 hours ago

Voltas Shares (NSE: VOLTAS) Surge 3.89% as AC Sales Cross 1 Million Mark in Record Q1 FY27

Voltas shares (VOLATS) rallied sharply on June 22, 2026, climbing 3.89% to ₹1,419.50 on the NSE after the Tata Group company announced a landmark achievement. Voltas crossed the milestone of selling 1 million air conditioner units within the first three months of FY27, an industry first for the brand in that timeframe. Over the last…

Read more 12
Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
📅 2 hours ago

Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition

Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…

Read more 12
Tencent Holdings (HKG: 0700) at 434.00 HKD Up +1.41% as WeChat AI Assistant Testing Begins
📅 2 hours ago

Tencent Holdings (HKG: 0700) at 434.00 HKD Up +1.41% as WeChat AI Assistant Testing Begins

Tencent Holdings stock gained 1.41% to 434.00 HKD on June 22, 2026, driven by a concrete and timely AI catalyst. Tencent Holdings Ltd. has started testing a new AI assistant for WeChat, known as Xiaowei, making it available to a small number of users, with users able to interact via text or voice to complete…

Read more 12
NSW Rail Corridor Rules Block $20M Woolooware Development, June 21
📅 24 hours ago

NSW Rail Corridor Rules Block $20M Woolooware Development, June 21

NSW rail corridor protection zone blocks $20M Woolooware development. Height and density restrictions force developers to withdraw from project.

Read more 12

MYCO.NE News FAQ